TTNP Insider Trading

Insider Ownership Percentage: 2.70%
Insider Buying (Last 12 Months): $897,800.75
Insider Selling (Last 12 Months): $0.00

Titan Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Titan Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Titan Pharmaceuticals Share Price & Price History

Current Price: $1.06
Price Change: +0.30 (1.20%)
As of 09/26/2022 02:30 PM ET

This chart shows the closing price history over time for TTNP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Titan Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/6/2022David E LazarMajor ShareholderBuy1,165,975$0.77$897,800.752,587,108View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Titan Pharmaceuticals (NASDAQ:TTNP)

29.79% of Titan Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TTNP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Titan Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2022Millennium Management LLC63,106$35K0.0%+516.8%0.524%Search for SEC Filing on Google Icon
8/13/2022Virtu Financial LLC62,333$35K0.0%N/A0.518%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC240,710$0.14M0.0%+559.3%1.999%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC33,309$87K0.0%N/A0.338%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC53,097$0.14M0.0%+49.5%0.538%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.204,324$0.53M0.0%+180.7%2.071%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC16,882$50K0.0%N/A0.171%Search for SEC Filing on Google Icon
5/14/2021Credit Suisse AG23,200$69K0.0%N/A0.235%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp18,204$54K0.0%N/A0.185%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG23,459$70K0.0%+287.0%0.238%Search for SEC Filing on Google Icon
5/10/2021GSA Capital Partners LLP39,820$0.12M0.0%N/A0.404%Search for SEC Filing on Google Icon
3/9/2021tru Independence LLC3,500$11.52M0.0%N/A0.049%Search for SEC Filing on Google Icon
2/5/2021Koshinski Asset Management Inc.4,011$0.28M0.0%N/A0.056%Search for SEC Filing on Google Icon
2/2/2021Koshinski Asset Management Inc.4,011$0.28M0.1%N/A0.056%Search for SEC Filing on Google Icon
8/17/2020Private Advisor Group LLC211,000$65K0.0%N/A0.221%Search for SEC Filing on Google Icon
8/7/2020Virtu Financial LLC142,611$44K0.0%N/A0.149%Search for SEC Filing on Google Icon
7/31/2020UBS Group AG116,646$36K0.0%+54.9%0.122%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC320,400$62K0.0%N/A0.481%Search for SEC Filing on Google Icon
2/4/2020Virtu Financial LLC520,912$0.10M0.0%+1,403.8%0.938%Search for SEC Filing on Google Icon
8/14/2019Vanguard Group Inc.582,180$0.75M0.0%+23.0%4.082%Search for SEC Filing on Google Icon
8/14/2019A.R.T. Advisors LLC69,645$89K0.0%+164.7%0.488%Search for SEC Filing on Google Icon
4/22/2019Perkins Capital Management Inc.90,838$0.16M0.1%-83.3%0.677%Search for SEC Filing on Google Icon
2/13/2019Geode Capital Management LLC341,474$76K0.0%+256.0%2.627%Search for SEC Filing on Google Icon
1/16/2019Virtu Financial LLC236,182$53K0.0%+530.0%0.303%Search for SEC Filing on Google Icon
12/13/2018Vanguard Group Inc432,337$90K0.0%+12.7%0.554%Search for SEC Filing on Google Icon
10/22/2018Perkins Capital Management Inc.1,200,000$0.25M0.1%N/A5.660%Search for SEC Filing on Google Icon
2/15/2018Millennium Management LLC127,749$0.17M0.0%-41.4%0.603%Search for SEC Filing on Google Icon
2/13/2018Renaissance Technologies LLC552,200$0.73M0.0%+25.4%2.605%Search for SEC Filing on Google Icon
8/14/2017Goldman Sachs Group Inc.102,503$0.20M0.0%+1.6%0.483%Search for SEC Filing on Google Icon
8/3/2017LMR Partners LLP55,034$0.11M0.0%N/A0.260%Search for SEC Filing on Google Icon
7/26/2017Municipal Employees Retirement System of Michigan303,300$0.58M0.0%N/A1.430%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Titan Pharmaceuticals logo
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.
Read More on Titan Pharmaceuticals

Today's Range

Now: $1.06
Low: $1.05
High: $1.08

50 Day Range

MA: $1.36
Low: $1.06
High: $1.58

52 Week Range

Now: $1.06
Low: $0.35
High: $2.03

Volume

1,400 shs

Average Volume

359,600 shs

Market Capitalization

$15.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.15

Who are the company insiders with the largest holdings of Titan Pharmaceuticals?

Titan Pharmaceuticals' top insider shareholders include:
  1. David E Lazar (Major Shareholder)
Learn More about top insider investors at Titan Pharmaceuticals.

Who are the major institutional investors of Titan Pharmaceuticals?

Titan Pharmaceuticals' top institutional investors include:
  1. Renaissance Technologies LLC — 2.00%
  2. Millennium Management LLC — 0.52%
  3. Virtu Financial LLC — 0.52%
  4. Group One Trading L.P. — 0.00%
Learn More about top institutional investors of Titan Pharmaceuticals stock.

Which major investors are buying Titan Pharmaceuticals stock?

Within the last quarter, TTNP stock was bought by institutional investors including:
  1. Renaissance Technologies LLC
  2. Virtu Financial LLC
  3. Millennium Management LLC
  4. Group One Trading L.P.